Blues Plans Sue CVS, Alleging It Overcharged for Generic Drugs
June
11
In a move that one attorney says may have a domino effect, Blue Cross Blue Shield plans recently filed suit against CVS Health Corp., claiming that the firm fraudulently overcharged them for generic drugs by “submitting claims for payment at artificially inflated prices.” CVS strongly denies the allegations.
The lawsuit, filed May 27 by Blues plans in Alabama, Florida, Minnesota, North Carolina, North Dakota and Kansas City, Mo., joins several others lodged against CVS and separately, against Walgreen Co., that allege the pharmacy chains failed to count prices in their generic cash discount programs when calculating “usual and customary” (U&C) prices for plan reimbursement.
© 2024 MMIT
Meet Our Reporters
-
Jill Drachenberg Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jill Drachenberg's Profile -
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile
